Adiponectin in obese women with T2DN [type 2 diabetes mellitus] and effects by RAS [renin angiotensin system] [losartan] blocker
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Losartan (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 03 Dec 2007 New trial record.
- 21 Nov 2007 Biomarkers information updated